0001209191-17-053312.txt : 20170919
0001209191-17-053312.hdr.sgml : 20170919
20170919165800
ACCESSION NUMBER: 0001209191-17-053312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170918
FILED AS OF DATE: 20170919
DATE AS OF CHANGE: 20170919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdollahian Neil
CENTRAL INDEX KEY: 0001678223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 171092509
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-18
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001678223
Abdollahian Neil
6310 NANCY RIDGE DR
SUITE 101
SAN DIEGO
CA
92121
0
1
0
0
Chief Business Officer
Common Stock
2017-09-18
4
A
0
15000
0.00
A
20421
D
Restricted Stock Unit
2017-09-18
4
M
0
25000
0.00
A
Common Stock
25000
25000
D
1/3rd of the total number of shares subject to the restricted stock unit shall vest on each December 31 of 2018, 2019 and 2020.
Includes 1,421 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 19, 2017.
Restricted stock units convert into common stock on a one-for-one basis.
A portion of the shares vest upon the achievement of various clinical and corporate milestones.
/s/ Marc Wilson, Attorney-in-fact
2017-09-19